Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Charlotte Beaudart, Jean Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan, Ivan Bautmans, Jürgen Bauer, Nansa Burlet, Matteo Cesari, Antonio Cherubini, Cyrus Cooper, Alfonso J. Cruz-Jentoft, Bess Dawson-Hughes, Roger A. Fielding, Nicholas C. Harvey, Francesco Landi, Andrea Laslop, Stefania Maggi, Beatriz Montero-Errasquin, Prieto Yerro María Concepción, Yves Rolland, René RizzoliMarjolein Visser, Olivier Bruyère

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

34 Téléchargements (Pure)


Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures that emphasize the lived experience of patients suffering from specific diseases is very important. In the field of sarcopenia, the only validated specific health-related quality of life (HRQoL) instrument available is the Sarcopenia Quality of Life questionnaire (SarQoL). This self-administrated HRQoL questionnaire, developed in 2015, consists of 55 items arranged into 22 questions and has currently been translated into 35 languages. Nineteen validation studies performed on SarQoL have consensually confirmed the capacity of SarQoL to detect difference in HRQoL between older people with and without sarcopenia, its reliability and its validity. Two further observational studies have also indicated its responsiveness to change. A short form SarQoL, including only 14 items has further been developed and validated to reduce the potential burden of administration. Research on the psychometric properties of SarQoL questionnaire is still encouraged as the responsiveness to change of SarQoL has not yet been measured in the context of interventional studies, as limited prospective data currently exist and as there is still not cut-off score to define a low HRQoL. In addition, SarQoL has mainly been used in community-dwelling older individuals with sarcopenia and would benefit to be studied in other types of populations. This review aims to provide to researchers, clinicians, regulators, pharmaceutical industries and other stakeholders a clear summary of comprehensive evidence on the SarQoL questionnaire published up to January 2023Query.

langue originaleAnglais
Pages (de - à)1581-1593
Nombre de pages13
journalAging Clinical and Experimental Research
Numéro de publication8
Les DOIs
Etat de la publicationPublié - août 2023
Modification externeOui

Empreinte digitale

Examiner les sujets de recherche de « Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation